Skip to content

Massachusetts General Hospital at American Urological Association's 2019 Annual Meeting

Specialists from the Massachusetts General Hospital Department of Urology will present on leading research and innovative treatment approaches at the American Urological Association’s 2019 Annual Meeting.

Specialists from the Massachusetts General Hospital Department of Urology will present on leading research and innovative treatment approaches.

Featured topics include:

  • Renal cell carcinoma
  • Renal stones
  • Stone disease
  • Stone prevention
  • Prostate cancer
  • Prostatectomy
  • Incontinence
  • Urolithiasis
  • Muscle-invasive bladder cancer treatment

About Urology at Mass General

The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments in every specialty of male and female urology. U.S. News & World Report consistently ranks the Mass General Department of Urology among the best in the nation.

Each year, our doctors perform over 5,000 surgeries and procedures to treat the full spectrum of urological conditions, including:

  • All genitourinary cancers
  • Kidney stones
  • Infertility
  • Voiding dysfunctions, such as incontinence
  • Prostate-related diseases (e.g., cancer)
  • Neuro-urology
  • Female urology
  • General urology

Our department is a recognized leader in investigating the causes of prostate and bladder cancer and developing preventative methods, treatments and cures for various urological diseases and disorders.

Michael L. Blute, MD, chief of the Department of Urology


Douglas M. Dahl, MD, chief of the Division of Urologic Oncology


Brian Eisner, MD, co-director of the Kidney Stone Program

Instructional Course Faculty

Podium Session Moderator


Francis J. McGovern, MD, urologist 

Instructional Course

Adam S. Feldman, MD, MPH, urologic oncologist, Jason Efstathiou, MD, DPhil, director of the Genitourinary Service, Richard Lee, MD, PhD, assistant physician in the Department of Medicine

Instructional Course

Ajay Singla, MD, FACS, FRCS, director of the Harvard Urologic Surgery Residency Program

Instructional Course

Melissa Huynh, MD, Urology Service fellow


Melissa Huynh, MD, Urology Service fellow, Dan Pucheril, MD, urologist, Dimitar Zlatev, MD, urologist


  • Developing a Comorbidity Risk Score to Predict Complications After Partial Nephrectomy for Localized Renal Cell Carcinoma.

Dayron Rodriguez, MD, MPH, Urology resident, Kai Li, MD, Urologic Surgery resident, et al

Moderated Poster

Tammer Yamany, MD, urologist, Michal Ursiny, MD, Surgery/Urology resident, Brian Eisner, MD, co-director of the Kidney Stone Program


Alice Yu, MD, Urologic Oncology fellow


Edouard Nicaise, research assistant in the Department of Urology

Moderated Poster